A mild and efficient copper-catalyzed coupling of aryl iodides and thiols using an oxime–phosphine oxide ligand
作者:Di Zhu、Lei Xu、Fan Wu、Boshun Wan
DOI:10.1016/j.tetlet.2006.05.178
日期:2006.8
A mild and efficient copper-catalyzed system for the coupling of aryliodides and thiols was developed using a readily prepared and highly stable oxime–phosphine oxide ligand. Good to excellent yields were obtained.
C-S cross-coupling of aryl halides with alkyl thiols catalyzed by in-situ generated nickel(II) N-heterocyclic carbene complexes
作者:Fang-Jie Guo、Jing Sun、Zhao-Qing Xu、Fritz E. Kühn、Shu-Liang Zang、Ming-Dong Zhou
DOI:10.1016/j.catcom.2017.02.007
日期:2017.6
C-S cross-coupling of aryl halides with alkyl thiols catalyzed by in-situ generated Ni (II) N-heterocyclic carbene (NHC) complexes is investigated. Good to excellent yields can be obtained for a variety of aryl halides when using 5 mol% of the Ni (II)-NHC catalyst and 1.5 eq. of KOtBu. Both the electronic and steric effects of the NHC ligands on the catalytic performance of Ni (II)-NHC, as well as the
[EN] ALLOSTERIC BINDING COMPOUNDS<br/>[FR] COMPOSÉS DE LIAISON ALLOSTÉRIQUES
申请人:UNIV AARHUS
公开号:WO2010094289A1
公开(公告)日:2010-08-26
The present invention relates to allosteric binding compounds of formula (I), especially for the treatment of CNS disorders, together with pharmaceutical compositions and methods of treatment including these compounds.
Metal–organic framework MOF-199-catalyzed direct and one-pot synthesis of thiols, sulfides and disulfides from aryl halides in wet polyethylene glycols (PEG 400)
several techniques including FT-IR, XRD, EDX and scanning electron microscopy. The MOF-199 used as an efficient catalyst for one-pot synthesis of thiols by domino reactions of aryl halides and thiourea, and subsequently conversion to aryl alkyl sulfides and diaryl disulfides in polyethyleneglycols (PEGs). A variety of aryl alkyl sulfides can be obtained in good to excellent yields in a relatively short
The present invention relates to allosteric binding compounds of formula (I), especially for the treatment of CNS disorders, together with pharmaceutical compositions and methods of treatment including these compounds.